Program
Insulin, Regular, Human
Also written as “Technosphere Insulin”, “inhaled human insulin” and “Human Insulin Inhalation Powder”.
Its studies are mostly in Diabetes Mellitus, Type 2 · Diabetes Mellitus, Type 1 · Diabetes Mellitus · Asthma · Diabetes, Gestational, led by 13 companies.
Drug pageInsulin, Regular, Human: every studyMany companies study it; this page follows only the 79 they lead. All 127 studies, academic ones too, with its approvals and label.Who develops it
Each company that leads studies of it, as its sponsor page counts them.
| Company | Studies it leads | Furthest phase | First study | Next primary completion |
|---|---|---|---|---|
| Mannkindits history only | 261 open or running | phase 4since Apr 16, 2021 | Mar 27, 2006 | Mar 2027phase 2 · NCT07224321 |
| Novo Nordisk | 190 open or running | phase 4since Aug 10, 2006 | Jul 17, 2003 | none ahead |
| Eli Lillyits history only | 100 open or running | phase 4since Jan 22, 2013 | Aug 4, 2005 | none ahead |
| Biodelits history only | 50 open or running | phase 3since Oct 5, 2007 | Oct 5, 2007 | none ahead |
| Pfizerits history only | 40 open or running | phase 3since Feb 2, 2006 | Feb 2, 2006 | none ahead |
| Dance Biopharmits history only | 30 open or running | phase 2since Mar 9, 2016 | Mar 9, 2016 | none ahead |
| Halozyme Therapeuticsits history only | 30 open or running | phase 2since Oct 15, 2008 | Jun 24, 2008 | none ahead |
| Sanofiits history only | 30 open or running | phase 4since Jun 26, 2012 | Sep 2, 2010 | none ahead |
| Transdermal Delivery Solutionsits history only | 21 open or running | phase 3since Dec 1, 2021 | Apr 21, 2021 | Oct 15, 2027phase 3 · NCT05159453 |
| Diabetes and Glandular Disease Clinicits history only | 10 open or running | phase 4since Oct 9, 2019 | Oct 9, 2019 | none ahead |
| ikfe-CROits history only | 10 open or running | phase 4since Dec 5, 2011 | Dec 5, 2011 | none ahead |
| Informed Data Systemsits history only | 10 open or running | phase 4since Oct 10, 2017 | Oct 10, 2017 | none ahead |
| The United Laboratories Internationalits history only | 10 open or running | phase 1since May 5, 2026 | May 5, 2026 | none ahead |
Also a collaborator on its studies: Langford Research Institute, Insulet, DexCom, Profil Institut für Stoffwechselforschung, Alkermes, WCCT Global and Nektar Therapeutics.
How these companies relate is not in the registry. A license or acquisition is shown only with a dated source, such as a company release or filing.
History and studies of Novo Nordisk only; the figures above count every company.
History and what’s ahead
From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.
Before these, 3 studies since Jul 17, 2003.
- Jul 5, 2006Phase 3 study in Diabetes MellitusNCT00348712 · 301 enrolled · Austria, Finland, France and more
- Aug 10, 2006Phase 4 study in Diabetes MellitusNCT00365170 · 419 enrolled · Argentina, Austria, Bulgaria and more
- Dec 11, 2006No phase study in Diabetes MellitusNCT00410033 · 74 enrolled · Sweden
- Jan 8, 2007Phase 1 study in Diabetes MellitusNCT00419718 · 23 enrolled · Austria
- Jan 25, 2007Phase 3 study in Diabetes MellitusNCT00427154 · 227 enrolled · United States
- May 3, 20073 phase 3 studies in Diabetes MellitusNCT00469586, NCT00472953, NCT00476437
- Aug 29, 2007Phase 3 study in Diabetes MellitusNCT00523042 · 10 enrolled · United States, Australia, Former Serbia and Montenegro and more
- Nov 30, 2007Phase 2 study in Diabetes MellitusNCT00567775 · 27 enrolled · Denmark
- Dec 5, 2007Phase 3 study in Diabetes MellitusNCT00569400 · 241 enrolled · Australia, Hong Kong, Malaysia and more
- Feb 6, 2008Phase 3 study in Diabetes MellitusNCT00617565 · 219 enrolled · China
- May 9, 2008Phase 4 study in Diabetes MellitusNCT00676819 · 19 enrolled · Germany
- Jul 29, 2008Phase 3 study in Diabetes MellitusNCT00725036 · 305 enrolled · Australia
- Jan 3, 2011Phase 1 study in Diabetes MellitusNCT01269606 · 13 enrolled · Japan
- Oct 5, 2011Phase 1 study in Diabetes MellitusNCT01448070 · 28 enrolled · United Kingdom
TargetBeta
Not stated by its company or a source we have read. Most early programs say nothing of it.
Studies
All 19 Novo Nordisk leads, newest first. Each opens its study page.
| Study | Phase | Status | Primary completion | Size |
|---|---|---|---|---|
| NCT01448070Diabetes Mellitus · United Kingdom | 1 | Completed | Dec 20, 2002 | 28 |
| NCT01269606Diabetes Mellitus · Japan | 1 | Completed | Mar 2011 | 13 |
| NCT00725036Diabetes Mellitus · Australia | 3 | Completed | Dec 14, 2004 | 305 |
| NCT00676819Diabetes Mellitus · Germany | 4 | Completed | Jul 19, 2002 | 19 |
| NCT00617565Diabetes Mellitus · China | 3 | Completed | Nov 26, 2003 | 219 |
| NCT00569400Diabetes Mellitus · Australia, Hong Kong, Malaysia and more | 3 | Completed | Jan 19, 2004 | 241 |
| NCT00567775Diabetes Mellitus · Denmark | 2 | Completed | Nov 20, 2002 | 27 |
| NCT00523042Diabetes Mellitus · United States, Australia, Former Serbia and Montenegro and more | 3 | Terminated | Feb 28, 2008 | 10 |
| NCT00476437Diabetes Mellitus · Japan | 3 | Completed | Nov 2007 | 81 |
| NCT00472953Diabetes Mellitus · Argentina, India, Romania and more | 3 | Terminated | Mar 5, 2008 | 38 |
| NCT00469586Diabetes Mellitus · Argentina, Austria, Belgium and more | 3 | Terminated | Apr 24, 2008 | 174 |
| NCT00427154Diabetes Mellitus · United States | 3 | Terminated | Mar 11, 2008 | 227 |
| NCT00419718Diabetes Mellitus · Austria | 1 | Completed | Nov 2005 | 23 |
| NCT00410033Diabetes Mellitus · Sweden | – | Completed | May 2006 | 74 |
| NCT00365170Diabetes Mellitus · Argentina, Austria, Bulgaria and more | 4 | Completed | Apr 2005 | 419 |
| NCT00348712Diabetes Mellitus · Austria, Finland, France and more | 3 | Terminated | Mar 5, 2008 | 301 |
| NCT00343980Diabetes Mellitus · Australia, Croatia, India and more | 3 | Terminated | Mar 10, 2008 | 363 |
| NCT00331604Diabetes Mellitus · Brazil, Denmark, France and more | 3 | Terminated | May 5, 2008 | 618 |
| NCT00065130Diabetes Mellitus · United States | 3 | Completed | Dec 2003 | 27 |
How it is read
Names in the registry
- “Technosphere Insulin”, 13 entries
- “inhaled human insulin”, 12 entries
- “Human Insulin Inhalation Powder”, 7 entries
- “human insulin”, 7 entries
- “Technosphere® Insulin Inhalation Powder”, 5 entries
Codes read as this program: INH69, INH139, INH208, HR1799.
Conditions, from the studies’ own filings
- Diabetes Mellitus, Type 2, 33 studies
- Diabetes Mellitus, Type 1, 29 studies
- Diabetes Mellitus, 10 studies
- Asthma, 1 study
- Diabetes, Gestational, 1 study
First seen by our ledger Nov 13, 2026.
What this can’t show
- Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
- Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
- Primary completion dates are the sponsors’ estimates and often move.
- A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.